Raymond James raised the firm's price target on Camden National to $56 from $54 and keeps an Outperform rating on the shares. Camden National reported a solid Q1 with stable loan balances, a pause in core net interest margin expansion, and strong fee income growth alongside better-than-expected expense control and stable credit quality, the analyst tells investors in a research note.
